Stock Research for FOLD


Featured Broker: Ally Invest

Get the due diligence for another stock.


FOLD Stock Chart & Research Data

The FOLD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FOLD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


FOLD Due diligence Resources & Stock Charts

The FOLD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FOLD Detailed Price Forecast - CNN Money CNN View FOLD Detailed Summary - Google Finance
Yahoo View FOLD Detailed Summary - Yahoo! Finance Zacks View FOLD Stock Research & Analysis -

Stock Analysis

TradeIdeas View FOLD Trends & Analysis - Trade-Ideas Barrons View FOLD Major Holders - Barrons
NASDAQ View FOLD Call Transcripts - NASDAQ Seeking View FOLD Breaking News & Analysis - Seeking Alpha
Spotlight View FOLD Annual Report - OTC Report View FOLD OTC Short Report -
TradeKing View FOLD Fundamentals - TradeKing Charts View FOLD SEC Filings - Bar Chart
WSJ View Historical Prices for FOLD - The WSJ Morningstar View Performance/Total Return for FOLD - Morningstar
MarketWatch View the Analyst Estimates for FOLD - MarketWatch CNBC View the Earnings History for FOLD - CNBC
StockMarketWatch View the FOLD Earnings - StockMarketWatch MacroAxis View FOLD Buy or Sell Recommendations - MacroAxis
Bullish View the FOLD Bullish Patterns - American Bulls Short Pains View FOLD Short Pain Metrics -

Social Media Mentions

StockTwits View FOLD Stock Mentions - StockTwits PennyStocks View FOLD Stock Mentions - PennyStockTweets
Twitter View FOLD Stock Mentions - Twitter Invest Hub View FOLD Investment Forum News - Investor Hub
Yahoo View FOLD Stock Mentions - Yahoo! Message Board Seeking Alpha View FOLD Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for FOLD - Insider Cow View Insider Transactions for FOLD - Insider Cow
CNBC View FOLD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FOLD - OTC Markets
Yahoo View Insider Transactions for FOLD - Yahoo! Finance NASDAQ View Institutional Holdings for FOLD - NASDAQ

Stock Charts

FinViz View FOLD Stock Insight & Charts - StockCharts View FOLD Investment Charts -
BarChart View FOLD Stock Overview & Charts - BarChart Trading View View FOLD User Generated Charts - Trading View

Latest Financial News for FOLD

Why Amicus Therapeutics Is Up 10% Today
Posted on Thursday September 20, 2018

The company is expanding its pipeline of gene therapies.

[$$] Amicus to Acquire Gene Therapy Company Celenex
Posted on Thursday September 20, 2018

Inc. said it has agreed to acquire clinical-stage gene therapy company Celenex for $100 million in cash, giving the publicly traded biotechnology company entry into gene therapies. Celenex has licensed a few pivotal and potentially first-to-market gene therapy programs to fight Batten disease, a fatal disorder that affects the nervous system in children. Under the acquisition agreement, Celenex’s shareholders are eligible for up to $277 million if significant development, submission and approval milestones are met, and up to $75 million in tiered sales.

Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
Posted on Thursday September 20, 2018

License with Nationwide Children’ s Hospital through the Acquisition of Celenex Establishes Amicus as Leading Gene Therapy Company in Neurologic Lysosomal Storage Disorders with Potential to Transform ...

7 Biotech Stocks to Buy Now
Posted on Wednesday September 19, 2018

Now that the biotechnology sector is well on its way to bouncing back after bottoming in May 2018, investors may feel like they missed out. The fears that previously plagued biotech stocks are no longer as big a threat. The government is no longer putting companies hiking drug price in their cross-hairs, at least not for now. This favorable environment should help biotech firms carry out their plans for the rest of the year.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.